Replies to post #281504 on Anavex Life Sciences Corp (AVXL)

[XenaLives]

Who has claimed or presented prevention when?

Blarcamesine has been discussed as a possible prhophylactic, but not necessarily when administered to people with disease states such as those in the current trial.

The commentary below is all based on premises that seem to be unfounded or misunderstood:

HOW do you present/claim prevention and still show decline albeit small and also compare the data you cite to placebo?

Saved me a bunch of money and I do not
even have to explain to my investment group. The rest may be luck, but I'll take what my skepticism gives me.

Anavex may continue to find funding to pursue the dream, but it won't be through Cowan and the process will extend past 2021 for sure.

If Only investing were as simple as a spelling B. Time to re allocate some funds to Alcoa by the reactions I've seen.

[XenaLives]

Very simple - prevention will be achieved in earlier stage disease.

This is not the population being tested now.